NEW YORK (GenomeWeb) – The Broad Institute today announced it has received a $10 million gift from the Gerstner Family Foundation to study how tumors acquire drug resistance.

The gift will support experimental cancer research at the Broad and clinical research in collaboration with Dana-Farber Cancer Institute, Harvard Cancer Center, and Memorial Sloan Kettering Cancer Center, the Broad Institute said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.